Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta for Aneurysmal Subarachnoid Hemorrhage
NCT00140010Phase 2Completed
- Sponsor
- University of Cambridge
- Start
- Apr 2005
- Primary completion
- Mar 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in aneurysmal subarachnoid hemorrhage (SAH), sponsored by University of Cambridge. Started Apr 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00140010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140010.